(Q35176386)

6 August 2017

0 references

A pharmacogenomic method for individualized prediction of drug sensitivity (English)

1 reference

6 August 2017

1 reference

Avrum Spira

9

0 references

Stefanie S Jeffrey

10

object named as

Stefanie S Jeffrey

1 reference

6 August 2017

Adam L Cohen

1

1 reference

6 August 2017

Raffaella Soldi

2

1 reference

6 August 2017

Haiyu Zhang

3

1 reference

6 August 2017

Adam M Gustafson

4

1 reference

6 August 2017

Ryan Wilcox

5

1 reference

6 August 2017

Bryan E Welm

6

1 reference

6 August 2017

Jeffrey T Chang

7

1 reference

6 August 2017

Evan Johnson

8

1 reference

6 August 2017

Andrea H Bild

11

1 reference

6 August 2017

publication date

19 July 2011

1 reference

Molecular Systems Biology

6 August 2017

published in

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

page(s)

513

1 reference

Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Management of breast cancer with targeted agents: importance of heterogeneity. [corrected].

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

HER2 testing and subsequent trastuzumab treatment for breast cancer in a managed care environment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Novel designs and end points for phase II clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Gene-expression signatures in breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Supervised risk predictor of breast cancer based on intrinsic subtypes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Do 'basal-like' breast cancers really exist?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Gene expression predictors in breast cancer: current status, limitations and perspectives

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Comparison of prognostic gene expression signatures for breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Valproic acid as anti-cancer drug.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Molecular concepts analysis links tumors, pathways, mechanisms, and drugs

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Cellular responses to EGFR inhibitors and their relevance to cancer therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Mutations in PIK3CA are infrequent in neuroblastoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

The molecular portraits of breast tumors are conserved across microarray platforms

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Capturing complex 3D tissue physiology in vitro

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Repeated observation of breast tumor subtypes in independent gene expression data sets

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Molecular portraits of human breast tumours

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Activated Raf-1 causes growth arrest in human small cell lung cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

Valproic Acid Hepatotoxicity in Human Liver Slices

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159972

High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Individualized care for patients with cancer - a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

The Connectivity Map: a new tool for biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

The challenges of gene expression microarrays for the study of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Signatures guide drug choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

Sorting out breast-cancer gene signatures

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21772261

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMSB.2011.47

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MSB.2011.47

1 reference

6 August 2017

1 reference

6 August 2017

1 reference